All Articles

Robinhood shares have surged roughly 30% over the past month, fueled by strong retail trading activity and a wave of bullish analyst coverage. BTIG initiated the stock at Buy with a $125 target, and Goldman Sachs raised its target to $121 after record June activity across event contracts, options, equities and crypto. At its 'The World is Flat' event, the company publicly launched Robinhood Chain, a Layer 2 network built on Arbitrum for tokenized real-world assets, alongside

Delta Air Lines beat Wall Street expectations for the second quarter despite elevated fuel costs, reporting adjusted earnings of $1.56 per share versus $1.48 expected on revenue of $17.67 billion. Premium demand continues to outpace the main cabin: first class and other premium tickets brought in $6.92 billion for the quarter, edging out the $6.85 billion from coach. Delta reaffirmed its full-year earnings forecast of $6.50 to $7.50 per share and guided third-quarter profit a

Semiconductor stocks sold off Monday, led by a 15% plunge in memory maker SK Hynix in Seoul, pressuring AI hardware names across the board — including server maker Super Micro Computer — and pushing the Nasdaq down 1.6%. The slide comes at the start of a busy week: major U.S. banks kick off Q2 earnings season Tuesday, and the June Consumer Price Index report is expected to give fresh clues on the inflation outlook, with the 10-year Treasury yield ticking up to 4.60%.

Biohacker Gary Brecka’s Ultimate Longevity Center signs 200 franchise territories before opening a single location — even as legal scrutiny of 10X Health mounts.

Blueprint founder Bryan Johnson discloses an autoimmune gastritis diagnosis, drops rapamycin from his stack, and steps back as Blueprint raises $60M and hires a new CEO.

Harvard geneticist David Sinclair’s Life Biosciences wins FDA approval for the first partial epigenetic reprogramming trial in humans, targeting vision restoration.